Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 8,360.00
+290.00 (3.59%)
Sep 1, 2026, 3:30 PM KST
Chabiotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 746,495 | 1,119,423 | 641,458 | 1,103,200 | 731,488 | 1,122,398 | |
Market Cap Growth | -5.32% | 74.51% | -41.85% | 50.82% | -34.83% | 6.53% |
Enterprise Value | 1,809,621 | 2,054,224 | 1,469,347 | 1,696,532 | 1,285,209 | 1,452,752 |
Last Close Price | 8070.00 | 14670.00 | 10579.18 | 18084.31 | 12000.82 | 18416.64 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 44.03 | 44.03 | 44.03 | 44.03 | 44.03 |
PS Ratio | 0.57 | 0.88 | 0.61 | 1.16 | 0.87 | 1.54 |
PB Ratio | 0.73 | 1.33 | 0.87 | 1.68 | 1.12 | 1.42 |
P/TBV Ratio | 3.13 | 12.38 | 6.69 | 5.30 | 3.31 | 2.70 |
P/OCF Ratio | - | - | - | 84.74 | - | 42.76 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.38 | 1.62 | 1.41 | 1.78 | 1.52 | 2.00 |
EV/EBITDA Ratio | 27.13 | - | - | 59.79 | - | 42.40 |
EV/EBIT Ratio | 191.62 | - | - | - | - | 227.09 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.79 | 1.08 | 1.12 | 0.69 | 0.62 | 0.43 |
Debt / EBITDA Ratio | - | - | - | 15.85 | - | 9.96 |
Net Debt / Equity Ratio | 0.44 | 0.67 | 0.64 | 0.35 | 0.23 | 0.00 |
Net Debt / EBITDA Ratio | -17.84 | -663.23 | -31.57 | 8.03 | -7.10 | -0.07 |
Net Debt / FCF Ratio | -1.59 | -2.58 | -3.32 | -3.97 | -1.07 | 0.03 |
Asset Turnover | 0.51 | 0.54 | 0.54 | 0.57 | 0.54 | 0.51 |
Inventory Turnover | 19.51 | 18.30 | 20.83 | 20.41 | 22.23 | 20.46 |
Quick Ratio | 0.80 | 0.59 | 0.65 | 0.71 | 0.93 | 1.22 |
Current Ratio | 0.88 | 0.67 | 0.73 | 0.82 | 1.09 | 1.37 |
Return on Equity (ROE) | -1.80% | -18.63% | -1.62% | -0.85% | -9.64% | -3.06% |
Return on Assets (ROA) | -2.01% | -1.51% | -1.92% | -0.35% | -2.14% | 0.28% |
Return on Invested Capital (ROIC) | 24.34% | -4.37% | -5.73% | 1.95% | -6.74% | 0.92% |
Return on Capital Employed (ROCE) | -4.70% | -4.60% | -5.00% | -0.90% | -4.80% | 0.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.91% | -9.81% | -0.74% | -0.76% | -6.50% | -1.24% |
FCF Yield | -37.93% | -19.57% | -22.17% | -5.20% | -19.11% | -7.69% |
Buyback Yield / Dilution | -218.39% | -111.36% | 44.35% | -1.43% | -3.24% | -3.82% |